Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124316852 | 12431685 | 2 | F | 20160505 | 20160715 | 20160603 | 20160723 | EXP | GB-MHRA-ADR 23504404 | GB-009507513-1606GBR000965 | MERCK | 58.00 | YR | M | Y | 0.00000 | 20160723 | CN | IE | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124316852 | 12431685 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 12675 | TABLET | |||||||||
124316852 | 12431685 | 2 | SS | BORTEZOMIB | BORTEZOMIB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
124316852 | 12431685 | 3 | SS | FARYDAK | PANOBINOSTAT | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
124316852 | 12431685 | 4 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | 0 | |||||||||||
124316852 | 12431685 | 5 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Unknown | 0 | CREAM | ||||||||||
124316852 | 12431685 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | |||||||||||
124316852 | 12431685 | 7 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Unknown | 0 | |||||||||||
124316852 | 12431685 | 8 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Unknown | 0 | |||||||||||
124316852 | 12431685 | 9 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
124316852 | 12431685 | 10 | C | CALCITRIOL. | CALCITRIOL | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124316852 | 12431685 | 1 | Product used for unknown indication |
124316852 | 12431685 | 2 | Plasma cell myeloma |
124316852 | 12431685 | 3 | Product used for unknown indication |
124316852 | 12431685 | 4 | Product used for unknown indication |
124316852 | 12431685 | 5 | Product used for unknown indication |
124316852 | 12431685 | 6 | Product used for unknown indication |
124316852 | 12431685 | 7 | Product used for unknown indication |
124316852 | 12431685 | 8 | Product used for unknown indication |
124316852 | 12431685 | 9 | Product used for unknown indication |
124316852 | 12431685 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124316852 | 12431685 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124316852 | 12431685 | Abasia | |
124316852 | 12431685 | Asthenia | |
124316852 | 12431685 | Orthostatic hypotension | |
124316852 | 12431685 | Tremor | |
124316852 | 12431685 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124316852 | 12431685 | 2 | 20160412 | 20160505 | 0 | |
124316852 | 12431685 | 3 | 20160426 | 0 |